The READNA consortium includes projects to accelerate new breakthrough DNA sequencing technologies and methods to enhance existing analysis methods.

The consortium joins 18 European partners from both academia and industry, and launches with a €12m grant via the European Commission's seventh Framework Programme (FP7).

Participants come from a diverse range of scientific disciplines. The interdisciplinary nature of the consortium allows the exploration of novel concepts of nucleic acid analysis. Via the READNA project, results are expected to improve many aspects of patient care including the development of new personalised medical strategies and treatments.

The ultimate aim will be to progress technologies enabling sequencing of an entire human genome for 1000€ in less than one day.

More information

READNA website